期刊文献+

康柏西普玻璃体内注射联合眼底激光光凝治疗对糖尿病性黄斑水肿患者视力及黄斑中心厚度的影响 被引量:31

Effect of conbercept intravitreal injection and retinal laser photocoagulation treatment on vision and yellow spot center thickness of patients with DME
下载PDF
导出
摘要 目的:研究康柏西普玻璃体内注射联合眼底激光光凝治疗对糖尿病性黄斑水肿(DME)患者视力及黄斑中心厚度的影响。方法:选择2015-01~2016-06在我院眼科经眼底检查、眼底荧光素血管造影(FFA)及光学相干断层扫描检查(OCT)确诊的DME患者108例(108眼)作为研究对象,根据不同的治疗方法,采用随机数字表,分为实验组和对照组各54例(54眼),试验组予康柏西普玻璃体内注射联合眼底激光光凝术治疗,对照组予单一激光光凝术治疗,并在治疗前、治疗后1、2、3个月测量记录两组患者的最佳矫正视力(BCVA)、黄斑中心视网膜厚度(CMT),分析两组患者BCVA和CMT在不同测量时间点之间的差异。结果:对两组患者的BCVA和CMT分别采用两因素重复测量方差分析结果显示:治疗方法与测量时间点之间存在交互作用(P<0.01);不同治疗方法之间BCVA和CMT存在差异(P<0.05),试验组的BCVA和CMT测量指标好于对照组;不同测量时间点之间BCVA和CMT存在差异(P<0.05),BCVA均值随治疗时间延长而增加,相反CMT均值随治疗时间延长而减少。结论:康柏西普玻璃体内注射联合眼底激光光凝术治疗DME较单一激光光凝术治疗具有更显著的临床疗效,其能明显提高患者视力、减轻黄斑水肿。 Objective: To investigate the influence of conbercept intravitreal injection and retinal laser photocoagulation treatment on vision and yellow spot center thickness of patients with DME.Methods:A total of 108 cases (eye) in our hospital from January 2015 to June 2016 diagnosed by fundus examination,FFA, OCT were selected and divided into observation group and control group,54 cases in each group.Observation group was given conbercept-intravitreal injection and retinal laser photocoagulation treatment, control group was given simple laser photocoagulation treatment.Record the BCVA, CMT of the two groups 1,2,3 months before and after treatment, compare the difference of BCVA and CMT on different time points. Results: Analysis results showed that: treatment methods and measure time point had interaction effect (P 〈0.01). BCVA and CMT had difference of different treatment methods (P〈0.05) ,BCVA and CMT of observation group were better than control group; BCVA and CMT had difference at different measure time (P〈0.05), BCVA was increased with the prolong of treatment time,but CMT was declined.Conclusion: Conbercept intravitreal injection and retinal laser photocoagulation treatment has significant effect than simple laser photocoagulation treatment,it can obviously improve vision and lighten macular oedema.
出处 《西北国防医学杂志》 CAS 2017年第1期19-22,共4页 Medical Journal of National Defending Forces in Northwest China
关键词 黄斑水肿 康柏西普 激光光凝术 视力 黄斑中心厚度 DME, conbercept, laser photocoagulation, vision, yellow spot centerthickness
  • 相关文献

参考文献15

二级参考文献248

  • 1Isil Bahar Sayman Muslubas,Baran Kandemir,Ayse Yesim Aydin Oral,Suleyman Kugu,Metin Dastan.Long-term vision-threatening complications of phakic intraocular lens implantation for high myopia[J].International Journal of Ophthalmology(English edition),2014,7(2):376-380. 被引量:14
  • 2Nizar Saleh Abdelfattah,Mohamed Amgad,Ahmed A Salama,Marina E Israel,Ghada A Elhawary,Ahmed E Radwan,Mohamed M Elgayar,Tamer M EL Nakhal,Islam T Elkhateb,Heba A Hashem,Doha K Embaby,Amira A Elabd,Reem K Elwy,Magdi S Yacoub,Hamdy Salem,Mohamed Abdel-Baqy,Ahmad Kassem.Development of an Arabic version of the National Eye Institute Visual Function Questionnaire as a tool to study eye diseases patients in Egypt[J].International Journal of Ophthalmology(English edition),2014,7(5):891-897. 被引量:8
  • 3张锡钢,王雅君,栗印兰,陈莉.浅谈用丹参注射液与碘离子导入法治疗激光光凝术后并发症的临床疗效[J].当代医药论丛,2014,12(8):273-274. 被引量:1
  • 4Chen E,Park CH.Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy.Retina,2006,26:699-700.
  • 5Wroblewski JJ,Wells JA 3rd,Gonzales CR.Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion.Am J Ophthalmol,2010,149:147-154.
  • 6Campochiaro PA,Heier JS,Feiner L,Gray S,et al.Ranibizumab for macular edema following branch retinal vein occlusion:six-month primary end point Results of a phase Ⅲ study.Ophthalmology,2010,117:1102-1112.
  • 7Hung KH,Lee SM,Lee SY,et al.Intravitreal bevacizumab (avastin) in the treatment of macular edema associated with perfused retinal vein occlusion.J Ocul Pharmacol Ther,2010,26:85-90.
  • 8Chalam KV,Gupta SK,Grover S,et al.Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma.Eur J Ophthalmol,2008,18:255-262.
  • 9Avery RL,Pearlman J,Pieramici DJ.et a1.Intravitreal bevacizumab(Avastin)in the treatment of proliferative diabetic retinopathy.Ophthalmology,2006,113:l695.
  • 10Iliev ME,Domig D.Wolf-Schnurrbursch U,et al.Intravitreal bevacizumb (Avastin) in the treatment of neovascular glaucoma.Am J Ophthalmol,2006,142:1054-1056.

共引文献397

同被引文献255

引证文献31

二级引证文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部